[1]杨 洋,林生荣,胡 青,等.3D-CTBA联合3D打印技术在肺癌胸腔镜肺段切除术中的应用价值[J].陕西医学杂志,2023,52(9):1221-1224.[doi:DOI:10.3969/j.issn.1000-7377.2023.09.025]
 YANG Yang,LIN Shengrong,HU Qing,et al.Application value of 3D-CTBA combined with 3D printing technology in thoracoscopic segmentectomy of lung cancer[J].,2023,52(9):1221-1224.[doi:DOI:10.3969/j.issn.1000-7377.2023.09.025]
点击复制

3D-CTBA联合3D打印技术在肺癌胸腔镜肺段切除术中的应用价值
分享到:

《陕西医学杂志》[ISSN:1000-7377/CN:61-1281/TN]

卷:
52
期数:
2023年9期
页码:
1221-1224
栏目:
临床研究
出版日期:
2023-09-05

文章信息/Info

Title:
Application value of 3D-CTBA combined with 3D printing technology in thoracoscopic segmentectomy of lung cancer
作者:
杨 洋林生荣胡 青丁玉琴周 浩周晟劼周叶枫韩 鑫
(东台市人民医院胸心外科,江苏 东台 224200)
Author(s):
YANG YangLIN ShengrongHU QingDING YuqinZHOU HaoZHOU ShengjieZHOU YefengHAN Xin
(Department of Cardiothoracic Surgery,Dongtai People's Hospital,Dongtai 224200,China)
关键词:
肺癌 胸腔镜肺段切除术 三维计算机断层扫描支气管血管成像 3D打印 手术中转率 肺叶转换率 肺功能 术后并发症
Keywords:
Lung cancer Thoracoscopic segmentectomy Three-dimensional computed tomography bronchial angiography 3D printing Surgical conversion rate Lung lobe conversion rate Lung function Postoperative complications
分类号:
R 734.2
DOI:
DOI:10.3969/j.issn.1000-7377.2023.09.025
文献标志码:
A
摘要:
目的:探究三维计算机断层扫描支气管血管成像(3D-CTBA)联合3D打印技术在肺癌胸腔镜肺段切除术中的临床应用效果。方法:选取接受胸腔镜肺段切除术的肺癌患者90例,采用随机双色球法分为试验组(45例)和对照组(45例)。对照组患者在术前接受薄层CT增强扫描,试验组在对照组的基础上加用3D-CTBA联合3D打印技术。比较两组患者手术中转率、肺叶转换率、围手术期指标(手术时间、术中出血量、术后引流量),以及术前和术后第15天肺功能指标[用力肺活量(FVC)、肺一氧化碳弥散因子(TLCO)、每分钟最大通气量(MVV)]; 统计两组患者术后1个月并发症发生情况。结果:试验组手术中转率、肺叶转换率显著低于对照组(均P<0.05); 试验组手术时间、术中出血量、术后引流量显著低于对照组(均P<0.05)。术后第15天,两组患者FVC、TLCO、MVV水平低于术前,且试验组高于对照组(均P<0.05)。术后1个月内,试验组并发症总发生率低于对照组(P<0.05)。结论:在肺癌胸腔镜肺段切除术前应用3D-CTBA联合3D打印技术可对病灶位置进行定位,有效提升临床手术精准度和安全性,降低手术对患者的不良影响,有利于患者术后恢复。
Abstract:
Objective:To explore the clinical application effects of three-dimensional computed tomography bronchial angiography(3D-CTBA)combined with 3D printing technology in thoracoscopic segmentectomy of lung cancer.Methods:A total of 90 patients with lung cancer who received thoracoscopic segmentectomy were selected and divided into experimental group(45 cases)and control group(45 cases)by the random two-color ball method.The control group received thin-slice CT enhanced scanning before surgery,and the experimental group was additionally given 3D-CTBA combined with 3D printing technology on the basis of the control group.The surgical conversion rate,lung lobe conversion rate,perioperative indicators(surgical time,intraoperative blood loss,postoperative drainage volume)and lung function indicators(forced vital capacity [FVC],diffusing capacity of the lungs for carbon monoxide [TLCO],maximum ventilation volume per minute [MVV])before and 15 days after surgery were compared between the two groups.The complications at 1 month after surgery were counted in both groups.Results:The surgical conversion rate and lung lobe conversion rate in experimental group were significantly lower than those in control group(all P<0.05).The surgical time,intraoperative blood loss and postoperative drainage volume were significantly lower in experimental group than those in control group(all P<0.05).On the 15th day after surgery,the FVC,TLCO and MVV in both groups were significantly lower than those before surgery,and the indicators in experimental group were significantly higher than those in control group(all P<0.05).The total complication rate of experimental group was significantly lower than that of control group within 1 month after surgery(P<0.05).Conclusion:The application of 3D-CTBA combined with 3D printing technology before thoracoscopic segmentectomy for lung cancer can locate the lesion,effectively improve the accuracy and safety of clinical surgery,reduce the adverse effects of surgery on patients,and is conducive to postoperative recovery of patients.

参考文献/References:

[1] Sung H,Ferlay J,Siegel RL,et al.Global cancer statistics 2020:GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J].CA Cancer J Clin,2021,71(3):209-249.
[2] 何 婷,刘晓芳.基于细胞介导的免疫应答观察逐水饮治疗肺癌胸腔积液疗效及机制探究[J].陕西中医,2021,42(3):288-292.
[3] 肖 凌,王 洋,钱建新,等.生脉饮合沙参麦冬汤联合西药治疗晚期非小细胞肺癌疗效研究[J].陕西中医,2021,42(12):1696-1699.
[4] 李明涛,白 龙.血清白蛋白检测联合6 min步行试验对肺癌患者肺叶切除术后肺部并发症的预测价值[J].陕西医学杂志,2022,51(11):1385-1388.
[5] Zeng W,Zhang W,Zhang J,et al.Systematic review and meta-analysis of video-assisted thoracoscopic surgery segmentectomy versus lobectomy for stage Ⅰ non-small cell lung cancer[J].World J Surg Oncol,2020,18(1):44.
[6] Hu CG,Yang XT,Zhao M,et al.Three-dimensional computed tomography bronchography and angiography-guided thoracoscopic segmentectomy for pulmonary nodules[J].Surg Innov,2022,29(3):343-352.
[7] Hu W,Zhang K,Han X,et al.Three-dimensional computed tomography angiography and bronchography combined with three-dimensional printing for thoracoscopic pulmonary segmentectomy in stage ⅠA non-small cell lung cancer[J].J Thorac Dis,2021,13(2):1187-1195.
[8] 沈汝鑫,韩 斌,孙 贝,等.慢性肺曲霉菌病的胸腔镜手术治疗[J].临床肺科杂志,2020,25(12):1795-1799.
[9] 魏培坚,刘 健,谭 桐,等.胸腔镜经二尖瓣室间隔心肌切除术治疗左心室中部梗阻的肥厚型心肌病的早期效果[J].中华外科杂志,2023,61(3):214-219.
[10] 冯 喆,高继东,郑明非,等.微创胸腔镜手术治疗纵隔肿瘤临床效果及对患者血浆中皮质醇、促肾上腺皮质激素浓度的影响研究[J].陕西医学杂志,2020,49(7):848-850,913.
[11] 王 欢,刘 建,陈 剑,等.胸腔镜复杂肺段切除术治疗Ⅰ期非小细胞肺癌的围手术期效果[J].中国胸心血管外科临床杂志,2021,28(5):555-559.
[12] 胡俊熙,陆世春,孙 超,等.三维计算机断层扫描支气管血管成像联合荧光腔镜反染法在解剖性肺段切除术中的应用价值[J].中国微创外科杂志,2022,22(10):820-824.
[13] 申江峰,卢开进,贾卫光,等.3D-CTBA引导精准肺段切除治疗早期非小细胞肺癌46例临床分析[J].徐州医科大学学报,2021,41(9):690-692.
[14] 齐海亮,杨 阳,史雪娟,等.全胸腔镜下单操作孔解剖性肺段切除术治疗肺结核继发曲菌球[J].中国微创外科杂志,2022,22(3):218-221.
[15] 单一波,蒋薛伟,沈 飞,等.3D-CTBA联合Hookwire定位在胸腔镜肺段切除术中的应用[J].中华腔镜外科杂志(电子版),2020,13(5):265-269.
[16] 沈 晶,林 琳,刘文飞,等.胸部增强CT不同重组算法深度学习诊断肺结节良恶性[J].影像诊断与介入放射学,2021,30(1):25-28.
[17] 陈小宇,陈进军,陈瑞莹,等.靶扫描与多维重建对肺小结节密度分析在早期肺癌诊断中的价值[J].临床肺科杂志,2021,26(8):1251-1254.
[18] 殷志敏,陈良亮,王霄霖,等.三维CT支气管血管成像在解剖性肺段切除术中的应用研究进展[J].实用临床医药杂志,2020,24(3):5-9.
[19] 刘 让,陈李李,俞经生,等.Mimics三维重建技术在胸腔镜解剖性肺段切除手术中的应用效果分析[J].临床肺科杂志,2022,27(12):1845-1849.
[20] Liu X,Zhao Y,Xuan Y,et al.Three-dimensional printing in the preoperative planning of thoracoscopic pulmonary segmentectomy[J].Transl Lung Cancer Res,2019,8(6):929-937.
[21] 夏宗禹,王 琴,鲁 鹏.3D打印技术在复杂性肾结石经皮肾镜取石术联合输尿管软镜碎石术中应用效果观察[J].临床军医杂志,2022,50(12):1262-1264.

相似文献/References:

[1]贾丽娟,杜苏丰.重组新城疫病毒疫苗rlRVG对A549荷瘤小鼠瘤体生长的抑制作用[J].陕西医学杂志,2019,(1):6.
 JIA Lijuan,DU Sufeng..The tumor growth influence of recombinant NDV (rlRVG) on lung adenocarcinoma A549transfected in vivo[J].,2019,(9):6.
[2]江茂琼,贾钰铭△,叶文静,等.MDSCs对肺癌小鼠CD8+T细胞及生存期的影响研究[J].陕西医学杂志,2019,(3):293.
 JIANG Maoqiong,JIA Yuming,LI Ting,et al.Effect of MDSCs on CD8 T cells and survival time of lung cancer mice[J].,2019,(9):293.
[3]李君艳,陈国荣.肺癌患者凝血指标与临床特征的关系*[J].陕西医学杂志,2019,(6):718.
 LI Junyan,CHEN Guorong..The relationships between coagulation indicators and clinic characterisitics of patients with lung cancer[J].,2019,(9):718.
[4]王 玲,申 鸿.癌胚抗原、糖类抗原、CA125、血管生成素、细胞角蛋白19片段及甲胎蛋白检测在肺癌诊断中的临床研究*[J].陕西医学杂志,2019,(8):1080.
 WANG Ling,SHEN Hong..The value of tumor markers CEA,CA199,CA125,Ang-2,CYFRA211 and AFP in the diagnosis of lung cancer[J].,2019,(9):1080.
[5]韩 乐,陈文娟△,雷光焰,等.microRNA21、microRNA25在肺癌组织中的表达及意义*[J].陕西医学杂志,2019,(12):1596.
 HAN Le,CHEN Wenjuan,LEI Guangyan,et al.Expression and significance of microRNA21 and microRNA25 in lung cancer tissues[J].,2019,(9):1596.
[6]王 勇,张 勇,白正忠△.单操作孔完全胸腔镜与传统三孔胸腔镜治疗老年肺癌疗效对比研究*[J].陕西医学杂志,2019,(12):1670.
[7]常瑞霞,可春梅.血小板相关参数和凝血指标在肺癌治疗中的变化及意义[J].陕西医学杂志,2021,50(5):610.[doi:DOI:10.3969/j.issn.1000-7377.2021.05.024]
 CHANG Ruixia,KE Chunmei.Changes and significance of platelet-related parameters and coagulation indexes in treatment of lung cancer[J].,2021,50(9):610.[doi:DOI:10.3969/j.issn.1000-7377.2021.05.024]
[8]米卫国.负压引流管在单操作孔胸腔镜下肺癌根治术中的临床应用研究[J].陕西医学杂志,2021,50(7):839.[doi:DOI:10.3969/j.issn.1000-7377.2021.07.018]
 MI Weiguo.Application effect of negative pressure drainage tube in patients undergoing radical surgery for lung cancer under single-port thoracoscopy[J].,2021,50(9):839.[doi:DOI:10.3969/j.issn.1000-7377.2021.07.018]
[9]张玉琨,李 波,刘 静,等.迷走神经保护对胸腔镜下肺癌根治术后房颤发生的预防作用[J].陕西医学杂志,2021,50(10):1267.[doi:DOI:10.3969/j.issn.1000-7377.2021.10.023]
[10]米 婷,王雅宁.气管镜下宏基因组学二代测序技术在肺癌鉴别诊断中的临床应用价值[J].陕西医学杂志,2022,51(4):437.[doi:DOI:10.3969/j.issn.1000-7377.2022.04.012]

备注/Memo

备注/Memo:
基金项目:中国医药卫生事业发展基金会医药科研课题(C202212-018)
更新日期/Last Update: 2023-09-04